questionsmedicales.fr
Maladies du système stomatognathique
Maladies de la bouche
Maladies parodontales
Atrophie parodontale
Atrophie parodontale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Atrophie parodontale
Maladies parodontales
Sondage parodontal
Radiographie dentaire
Récession gingivale
Mobilité dentaire
Atrophie parodontale
Stabilisation
Antécédents médicaux
Facteurs de risque
Symptômes
5
Douleur dentaire
Mastication
Saignement gingival
Hygiène bucco-dentaire
Esthétique dentaire
Récession gingivale
Sensibilité dentaire
Atrophie parodontale
Prévention
5
Hygiène bucco-dentaire
Visites dentaires
Plaque dentaire
Brossage des dents
Rinçage buccal
Inflammation gingivale
Nutrition
Santé gingivale
Tabagisme
Maladies parodontales
Traitements
5
Détartrage
Chirurgie parodontale
Chirurgie parodontale
Restauration
Antibiotiques
Infections parodontales
Thérapie au laser
Inflammation
Anesthésie
Inconfort dentaire
Complications
5
Perte dentaire
Infections
Santé systémique
Maladies parodontales
Diabète
Contrôle glycémique
Qualité de vie
Estime de soi
Facteurs de risque
5
Stress
Système immunitaire
Maladies auto-immunes
Atrophie parodontale
Nutrition
Santé gingivale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Atrophie parodontale : Questions médicales les plus fréquentes",
"headline": "Atrophie parodontale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Atrophie parodontale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-09",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Atrophie parodontale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies parodontales",
"url": "https://questionsmedicales.fr/mesh/D010510",
"about": {
"@type": "MedicalCondition",
"name": "Maladies parodontales",
"code": {
"@type": "MedicalCode",
"code": "D010510",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Résorption alvéolaire",
"alternateName": "Alveolar Bone Loss",
"url": "https://questionsmedicales.fr/mesh/D016301",
"about": {
"@type": "MedicalCondition",
"name": "Résorption alvéolaire",
"code": {
"@type": "MedicalCode",
"code": "D016301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714.354.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récession gingivale",
"alternateName": "Gingival Recession",
"url": "https://questionsmedicales.fr/mesh/D005889",
"about": {
"@type": "MedicalCondition",
"name": "Récession gingivale",
"code": {
"@type": "MedicalCode",
"code": "D005889",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714.354.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perte d'attache parodontale",
"alternateName": "Periodontal Attachment Loss",
"url": "https://questionsmedicales.fr/mesh/D017622",
"about": {
"@type": "MedicalCondition",
"name": "Perte d'attache parodontale",
"code": {
"@type": "MedicalCode",
"code": "D017622",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714.354.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Atrophie parodontale",
"alternateName": "Periodontal Atrophy",
"code": {
"@type": "MedicalCode",
"code": "D055093",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Frederik Barkhof",
"url": "https://questionsmedicales.fr/author/Frederik%20Barkhof",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden."
}
},
{
"@type": "Person",
"name": "Maria Teresa Pellecchia",
"url": "https://questionsmedicales.fr/author/Maria%20Teresa%20Pellecchia",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", Neuroscience Section, University of Salerno, Baronissi, SA, Italy."
}
},
{
"@type": "Person",
"name": "Iva Stankovic",
"url": "https://questionsmedicales.fr/author/Iva%20Stankovic",
"affiliation": {
"@type": "Organization",
"name": "Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia."
}
},
{
"@type": "Person",
"name": "Gregor K Wenning",
"url": "https://questionsmedicales.fr/author/Gregor%20K%20Wenning",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria."
}
},
{
"@type": "Person",
"name": "Klaus Seppi",
"url": "https://questionsmedicales.fr/author/Klaus%20Seppi",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prostatic Urethral Length as a Predictor for Surgery in Benign Prostatic Hyperplasia.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36974872",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33314/jnhrc.v20i3.4613"
}
},
{
"@type": "ScholarlyArticle",
"name": "Is there a best timing for benign prostatic hyperplasia surgery?",
"datePublished": "2024-02-05",
"url": "https://questionsmedicales.fr/article/38717461",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.fjurol.2024.102574"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer.",
"datePublished": "2022-07-05",
"url": "https://questionsmedicales.fr/article/35865814",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcimb.2022.894777"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia.",
"datePublished": "2024-10-07",
"url": "https://questionsmedicales.fr/article/39373947",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11934-024-01235-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic arterial embolisation for men with benign prostatic hyperplasia: a Cochrane review.",
"datePublished": "2022-07-13",
"url": "https://questionsmedicales.fr/article/35696302",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/bju.15823"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système stomatognathique",
"item": "https://questionsmedicales.fr/mesh/D009057"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de la bouche",
"item": "https://questionsmedicales.fr/mesh/D009059"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies parodontales",
"item": "https://questionsmedicales.fr/mesh/D010510"
},
{
"@type": "ListItem",
"position": 5,
"name": "Atrophie parodontale",
"item": "https://questionsmedicales.fr/mesh/D055093"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Atrophie parodontale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Atrophie parodontale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Atrophie parodontale",
"description": "Comment diagnostiquer l'atrophie parodontale ?\nQuels tests sont utilisés pour évaluer l'atrophie ?\nQuels signes cliniques indiquent l'atrophie ?\nL'atrophie parodontale est-elle réversible ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Atrophie parodontale",
"description": "Quels sont les symptômes de l'atrophie parodontale ?\nL'atrophie parodontale cause-t-elle des douleurs ?\nPeut-on avoir des gencives qui saignent ?\nComment l'atrophie affecte-t-elle l'apparence des dents ?\nY a-t-il un lien entre l'atrophie et la sensibilité dentaire ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Atrophie parodontale",
"description": "Comment prévenir l'atrophie parodontale ?\nQuel rôle joue le brossage des dents ?\nLes produits de rinçage buccal sont-ils utiles ?\nL'alimentation influence-t-elle la santé parodontale ?\nFumer affecte-t-il la santé parodontale ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Atrophie parodontale",
"description": "Quels traitements sont disponibles pour l'atrophie parodontale ?\nLa chirurgie est-elle nécessaire pour traiter l'atrophie ?\nLes antibiotiques sont-ils utilisés dans le traitement ?\nComment la thérapie au laser aide-t-elle ?\nLes traitements sont-ils douloureux ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Atrophie parodontale",
"description": "Quelles complications peuvent survenir avec l'atrophie ?\nL'atrophie parodontale peut-elle affecter la santé générale ?\nY a-t-il un risque accru de diabète ?\nComment l'atrophie affecte-t-elle la qualité de vie ?\nLes infections parodontales peuvent-elles se propager ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Atrophie parodontale",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque d'atrophie ?\nLe stress a-t-il un impact sur la santé parodontale ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nUne alimentation déséquilibrée influence-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'atrophie parodontale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par un examen clinique et des radiographies dentaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'atrophie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des sondages parodontal et des radiographies sont utilisés pour évaluer la perte osseuse."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent l'atrophie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent la récession gingivale et la mobilité dentaire."
}
},
{
"@type": "Question",
"name": "L'atrophie parodontale est-elle réversible ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'atrophie parodontale est généralement irréversible, mais peut être stabilisée."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les facteurs de risque et les antécédents de maladies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'atrophie parodontale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des gencives enflammées, des douleurs et une mauvaise haleine."
}
},
{
"@type": "Question",
"name": "L'atrophie parodontale cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des douleurs lors de la mastication ou de la pression sur les dents."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des gencives qui saignent ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les gencives peuvent saigner lors du brossage ou de l'utilisation de fil dentaire."
}
},
{
"@type": "Question",
"name": "Comment l'atrophie affecte-t-elle l'apparence des dents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner un aspect plus long des dents en raison de la récession gingivale."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre l'atrophie et la sensibilité dentaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'atrophie peut augmenter la sensibilité dentaire aux aliments chauds ou froids."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'atrophie parodontale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène bucco-dentaire et des visites régulières chez le dentiste sont essentielles."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le brossage des dents ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le brossage régulier aide à éliminer la plaque dentaire et à prévenir les maladies parodontales."
}
},
{
"@type": "Question",
"name": "Les produits de rinçage buccal sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains rince-bouche antibactériens peuvent aider à réduire l'inflammation gingivale."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la santé parodontale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée riche en vitamines et minéraux favorise la santé des gencives."
}
},
{
"@type": "Question",
"name": "Fumer affecte-t-il la santé parodontale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de maladies parodontales et d'atrophie."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'atrophie parodontale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent le détartrage, le surfaçage radiculaire et la chirurgie parodontale."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle nécessaire pour traiter l'atrophie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie peut être nécessaire dans les cas avancés pour restaurer le tissu parodontal."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils utilisés dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques peuvent être prescrits pour traiter les infections parodontales."
}
},
{
"@type": "Question",
"name": "Comment la thérapie au laser aide-t-elle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie au laser peut réduire l'inflammation et favoriser la guérison des tissus parodontal."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils douloureux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent causer un certain inconfort, mais des anesthésiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'atrophie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de dents, des infections et des problèmes de mastication."
}
},
{
"@type": "Question",
"name": "L'atrophie parodontale peut-elle affecter la santé générale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études montrent un lien entre les maladies parodontales et des problèmes systémiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies parodontales peuvent aggraver le contrôle glycémique chez les diabétiques."
}
},
{
"@type": "Question",
"name": "Comment l'atrophie affecte-t-elle la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des douleurs, des difficultés à manger et une baisse de l'estime de soi."
}
},
{
"@type": "Question",
"name": "Les infections parodontales peuvent-elles se propager ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections peuvent se propager à d'autres parties du corps, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, le diabète, et une mauvaise hygiène bucco-dentaire."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'atrophie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'atrophie parodontale augmente avec l'âge en raison de l'usure des tissus."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur la santé parodontale ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et aggraver les maladies parodontales."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque d'atrophie parodontale."
}
},
{
"@type": "Question",
"name": "Une alimentation déséquilibrée influence-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation pauvre en nutriments peut affaiblir les gencives et favoriser l'atrophie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Baronissi, SA, Italy.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Division of Periodontology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Department of Periodontology, Endodontology and Cariology, University Centre for Dental Medicine, University of Basel, Basel, Switzerland.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Periodontology Clinical Trials Group, University of Bristol, Bristol, UK.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Oral Disease, West China Hospital of Stomatology, National Clinical Research Center for Oral Diseases, Sichuan University, Chengdu, China.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Department of Neuro-Oncological Surgery, Neurosurgery Center, Zhujiang Hospital of Southern Medical University, Guangzhou, China. zyn1007@126.com.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Division of Pediatric Ophthalmology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Division of Pediatric Ophthalmology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Publications dans "Atrophie parodontale" :
Benign prostatic hyperplasia is associated with structural and morphological changes including elongation of prostatic urethral length. The aim of our study was to assess whether prostatic urethral le...
This prospective observational study was conducted over a 12-months duration. All the patients who presented with lower urinary tract symptoms secondary to benign prostatic hyperplasia were evaluated ...
A total of 153 patients were included in the study. Eighty-three (54.2%) patients underwent surgery during the study period. Prostate volume, intravesical prostatic protrusion, post-void residual volu...
BPH patients with longer PUL may require surgical management. PUL measured by TRUS may be a predicting factor for the need of surgery in BPH Keywords: Benign prostatic hyperplasia; lower urinary tract...
Treatment of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH) has shifted over the last decades, with medical therapy becoming the primary treatment modality while sur...
A literature search was conducted on Pub-Med/MEDLINE database to identify reports published from January 1990 until January 2022 by combining the following MeSH terms: "Lower Urinary Tract Symptoms"; ...
The "pro early surgery" highlighted the superior efficacy and cost-effectiveness of surgery over medical treatment for BPH, as well as the possibility of worse postoperative outcomes for delayed surgi...
Clinical trials comparing the outcomes for prolonged medical therapy versus early surgical treatment could determine which approach is more beneficial in the long-term in context of the aging populati...
Apart from other risk factors, chronic inflammation is also associated with the onset of Prostate Cancer (PCa), wherein pathogen infection and tissue microbiome dysbiosis are known to play a major rol...
The prevalence of benign prostatic hyperplasia (BPH) is rising, however, current treatment options present severe complications and limit patient's quality of life. Accordingly, advancements in prosta...
The dual dilation and paxlitaxel eluting Optilume BPH Catheter System enhances promise in catheter-based treatments, providing the longest sustained increase in max urinary flow rate and decrease in p...
To assess the effects of prostatic arterial embolisation (PAE) compared to other procedures for treatment of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH)....
We included randomised controlled trials (RCTs), as well as non-randomised studies (NRSs) enrolling men with BPH undergoing PAE vs other surgical interventions via a comprehensive search up until 8 No...
We found data to inform two comparisons: PAE vs transurethral resection of prostate (TURP; six RCTs and two NRSs), and PAE vs sham (one RCT). This abstract focuses on the primary outcomes in a compari...
Compared to TURP, the impact on urological symptoms and QoL improvement as perceived by patients appears to be similar. This review did reveal major uncertainty as to how major adverse events compare....
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro...
To determine the correlation between the PSA, IPSS and PV in men of African descent....
This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital....
The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t...
The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w...
This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...
It is a known fact that the role of microRNAs (miRNA) has a very important place in cancer development and progression. miRNAs target a significant part of pathways as well as genes. This study aimed ...
Peripheral blood mononuclear cells (PBMCs) and tissue samples were collected from prostate cancer (PCa) (n: 20) and benign prostatic hyperplasia (BPH) (n: 20) patients. Total RNA isolation was perform...
In tissue samples, 37 different expressed miRNAs were identified in PCa patients compared to BPH patients. In PBMCs samples, 27 different expressed miRNAs were identified in PCa patients compared to b...
Our results suggested that determined common hsa-miR-494-3p, hsa-miR-3128, hsa-miR-8084 and their target HIF1A, AVRP1A, NHS, INSL4 may play a crucial role in therapeutic and early diagnostic strategie...
To compare the cost effectiveness of prostatic artery embolization (PAE) with that of transurethral resection of the prostate (TURP) for the treatment of medically refractory benign prostatic hyperpla...
A cost-effectiveness analysis with Markov modeling was performed, comparing the clinical course after PAE with that after TURP for 3 years. Probabilities were obtained from the available literature, a...
Base case calculation showed comparable outcomes (PAE, 2.845 QALY; TURP, 2.854 QALY), with a cost difference of $3,104 (PAE, $2,934; TURP, $6,038). The incremental cost-effectiveness ratio was $360,24...
PAE is a cost-effective strategy to treat medically refractory BPH, resulting in comparable health benefits at a lower cost than that of TURP even when accounting for extreme alterations in adverse ev...
Autophagy is a cellular homeostatic mechanism characterized by cyclic degradation. It plays an essential role in maintaining cellular quality and survival by eliminating dysfunctional cellular compone...
Interventions for benign prostatic hyperplasia have evolved from transurethral resection of the prostate and simple prostatectomy to a myriad of office-based and operating-room procedures. The contemp...